02
Sep

Tiny Mapp Biopharmaceutical’s much-scrutinized Ebola treatment proved 100% effective in animal studies, the company said, stoking hopes that the investigational therapy can help curb an outbreak of the virus.

…read more

Source: Mapp’s Ebola treatment comes through in a preclinical study

    

0 No comments